"MetaVia OXM analogue agonist meets endpoints in Phase Ib weight loss trial" was originally created and published by Clinical ...

MetaVia has shared an update on its attempt to crash the obesity party, reporting average weight loss of 9.1% in people who ...

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose ...

Manufacturer Novo Nordisk is now offering Wegovy in pill form, which some people prefer to the injections. The company has ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive statistically significant results from the 8-week ...

Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss ...

The Wegovy pill is only available in the U.S. with a doctor’s prescription. Patients can pick it up at pharmacies nationwide, ...

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to ...

MetaVia ( ($MTVA) ) has provided an announcement. On January 5, 2026, MetaVia reported positive, statistically significant data from the extended ...

Alignment on Phase 3 registrational trial parameters confirmed following receipt of minutes from end-of-phase 2 meeting with ...

Novo Nordisk is the first manufacturer to market its drug Wegovy in pill form in the U.S., though Eli Lilly expects approval ...